The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy
- PMID: 9543354
- DOI: 10.1023/a:1006812004945
The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy
Abstract
Duchenne muscular dystrophy (DMD) is the most common of the human muscular dystrophies, affecting approximately 1 in 3500 boys. Most DMD patients die in their late teens or early twenties due to involvement of the diaphragm and other respiratory muscles by the disease. The primary abnormality in DMD is an absence of dystrophin, a 427 kd protein normally found at the cytoplasmic face of the muscle cell surface membrane. Based upon the predicted structure and location of the protein, it has been proposed that dystrophin plays an important role in providing mechanical reinforcement to the sarcolemmal membrane of muscle fibers. Therefore, dystrophin could help to protect muscle fibers from potentially damaging tissue stresses developed during muscle contraction. In the present paper, the nature of mechanical stresses placed upon myofibers during various forms of muscle contraction are reviewed, along with current lines of evidence supporting a critical role for dystrophin as a subsarcolemmal membrane-stabilizing protein in this setting. In addition, the implications of these findings for exercise programs and other potential forms of therapy in DMD are discussed.
Similar articles
-
Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17. Exp Physiol. 2014. PMID: 24443351
-
Dystrophin: the protein product of the Duchenne muscular dystrophy locus.Cell. 1987 Dec 24;51(6):919-28. doi: 10.1016/0092-8674(87)90579-4. Cell. 1987. PMID: 3319190
-
Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice.Gene Ther. 1998 Mar;5(3):369-79. doi: 10.1038/sj.gt.3300600. Gene Ther. 1998. PMID: 9614557
-
Creatine kinase, cell membrane and Duchenne muscular dystrophy.Mol Cell Biochem. 1999 Jan;190(1-2):143-51. Mol Cell Biochem. 1999. PMID: 10098981 Review.
-
The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases.Muscle Nerve. 1993 Nov;16(11):1141-53. doi: 10.1002/mus.880161102. Muscle Nerve. 1993. PMID: 8413366 Review.
Cited by
-
Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles.J Physiol. 2013 Jan 15;591(2):559-70. doi: 10.1113/jphysiol.2012.241679. Epub 2012 Oct 29. J Physiol. 2013. PMID: 23109110 Free PMC article.
-
Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD.Cell Death Discov. 2023 Jul 4;9(1):224. doi: 10.1038/s41420-023-01503-0. Cell Death Discov. 2023. PMID: 37402716 Free PMC article.
-
Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins.Medicina (Kaunas). 2024 Jun 27;60(7):1060. doi: 10.3390/medicina60071060. Medicina (Kaunas). 2024. PMID: 39064489 Free PMC article. Review.
-
Trunk-oriented Exercises Versus Whole-body Vibration on Abdominal Thickness and Balance in Children with Duchene Muscular Dystrophy.J Musculoskelet Neuronal Interact. 2024 Mar 1;24(1):47-54. J Musculoskelet Neuronal Interact. 2024. PMID: 38427368 Free PMC article. Clinical Trial.
-
Selective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of duchenne muscular dystrophy.J Int Neuropsychol Soc. 2001 Jan;7(1):45-54. doi: 10.1017/s1355617701711058. J Int Neuropsychol Soc. 2001. PMID: 11253841 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical